Scientific Publications-2007-Neglected-Diseases

2007

Pragmatic and Principled: DNDi's Approach to IP Management by Banerji J and Pecoul B. Intellectual Property Management in Health and Agricultural Innovation: A Handbook of Best Practices (eds. A Krattiger, RT Mahoney, L Nelsen, et al.) 2007.
DNDi's mission is to develop safe, effective, and affordable new drugs for patients suffering from neglected diseases and to ensure equitable access to these drugs. DNDi believes that intellectual property (IP) rights should not pose a barrier to access to these medicines, and that a balanced approach to IP management is therefore critical. DNDi's IP policy articulates the organization’s approach to IP and ensures that products are accessible and affordable to patients who need them most. DNDi recognizes the reality of IP and seeks to implement its humanitarian mission using best, pragmatic practices for IP management. DNDi has already demonstrated that this is feasible, having successfully negotiated with both private and public sector institutions.
Click here to access the full article

Nature Outlook Neglected Diseases Supplement by various authors. Outlook: Neglected diseases 2007 Sep (449) , No. 7159 pp157-182
Tropical diseases affect more than one billion people, yet there are few effective treatments. And despite much research activity, scientific innovations with therapeutic potential are not making it out of the laboratory. The articles in this Outlook examine what can be done to stimulate the development of effective medicines and deliver them to the people who need them most.
Click here to download the full supplement [PDF] - (Nine chapters in PDF)

Neglected diseases: progress in drug development by Croft SL. Curr Opin Investig Drugs. 2007 Feb;8(2):103-4.
Click here to access the full article